The DOI matches its Crossref record; 276 of the 277 references it cites were found in a registry or an index.
Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms
Open accessAbstract
Leukodystrophies are genetically determined disorders characterized by the selective involvement of the central nervous system white matter. Onset may be at any age, from prenatal life to senescence. Many leukodystrophies are degenerative in nature, but some only impair white matter function. The clinical course is mostly progressive, but may also be static or even improving with time. Progressive leukodystrophies are often fatal, and no curative treatment is known. The last decade has witnessed a tremendous increase in the number of defined leukodystrophies also owing to a diagnostic approach combining magnetic resonance imaging pattern recognition and next generation sequencing. Knowledge on white matter physiology and pathology has also dramatically built up. This led to the recognition that only few leukodystrophies are due to mutations in myelin- or oligodendrocyte-specific genes, and many are rather caused by defects in other white matter structural components, including astrocytes, microglia, axons and blood vessels. We here propose a novel classification of leukodystrophies that takes into account the primary involvement of any white matter component. Categories in this classification are the myelin disorders due to a primary defect in oligodendrocytes or myelin (hypomyelinating and demyelinating leukodystrophies, leukodystrophies with myelin vacuolization); astrocytopathies; leuko-axonopathies; microgliopathies; and leuko-vasculopathies. Following this classification, we illustrate the neuropathology and disease mechanisms of some leukodystrophies taken as example for each category. Some leukodystrophies fall into more than one category. Given the complex molecular and cellular interplay underlying white matter pathology, recognition of the cellular pathology behind a disease becomes crucial in addressing possible treatment strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The astrocytic contribution of the TSPO signal could also complicate differentiation of multiple sclerosis from leukodystrophies that have significant astrocytic but not microglial involvement (van der Knaap and Bugiani, 2017).”
From A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis (2019) · cites this paper as van der Knaap and Bugiani, 2017
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
Pantoni, L. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70104-6 · Cited by 3,405
Dynamic instability of microtubule growth
Mitchison, T., & Kirschner, M. (1984) · Nature · doi:10.1038/312237a0 · Cited by 3,337
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
Miron, V. E., Boyd, A., Zhao, J.-W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., van Wijngaarden, P., Wagers, A. J., Williams, A., Franklin, R. J. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3469 · Cited by 1,777
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
Wardlaw, J. M., Smith, C., & Dichgans, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70060-7 · Cited by 1,657
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity
Fünfschilling, U., Supplie, L. M., Mahad, D., Boretius, S., Saab, A. S., Edgar, J., Brinkmann, B. G., Kassmann, C. M., Tzvetanova, I. D., Möbius, W., et al. (2012) · Nature · doi:10.1038/nature11007 · Cited by 1,523
Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain
Gibson, E. M., Purger, D., Mount, C. W., Goldstein, A. K., Lin, G. L., Wood, L. S., Inema, I., Miller, S. E., Bieri, G., Zuchero, J. B., et al. (2014) · Science · doi:10.1126/science.1252304 · Cited by 1,472
Research works printed but not linked: 6
- Agamanolis DP (2004) Pathology & genetics. Developmental neuropathology. ISN Neuropath, City
- Bielschowsky MH, Henneberg R (1928) Über familiäre diffuse Sklerose (Leukodystrophia cerebri progressiva hereditaria). J Psychol Neurol 36:131–181
- Pelizaeus F (1899) Überr eine eigenartige faimiliäre Entwicklungshemmung cornehmlich auf motorischem Gebiete. Archiv Psych 31:100
- Powers JM (2004) Peroxisomal disorders. In: Pathology & genetics. Developmental neuropathology. JA Golden, BN Harding (eds). ISN Neuropath Press, Basel. pp.287–295
- Suzuki K, Suzuki K (1996) The gangliosidoses. In: handbook of clinical neurology, RJ Vinken and GW Bruyn, Revised series Vol 22 (66) Neurodystrophies and neurolipidoses, HW Moser (ed) Elsevier Science B.V., Amsterdam, pp.247-280.
- Suzuki KV, Vanier M.T. (2004) Sphingolipidoses. In: Pathology & genetics. Developmental neuropathology. JA Golden, BN Arding (eds). ISN Neuropath, Basel. pp.235-236.
Cited by
Sorted by citations
Myelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes‐Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 799
Oosterhof, N., Chang, I. J., Karimiani, E. G., Kuil, L. E., Jensen, D. M., Daza, R., Young, E., Astle, L., van der Linde, H. C., Shivaram, G. M., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.03.010 · Cited by 247
Disease-associated oligodendrocyte responses across neurodegenerative diseases
Pandey, S., Shen, K., Lee, S.-H., Shen, Y.-A. A., Wang, Y., Otero-García, M., Kotova, N., Vito, S. T., Laufer, B. I., Newton, D. F., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111189 · Cited by 227
CSF1R -related leukoencephalopathy: A major player in primary microgliopathies
Konno, T., Kasanuki, K., Ikeuchi, T., Dickson, D. W., & Wszolek, Z. K. (2018) · Neurology · doi:10.1212/wnl.0000000000006642 · Cited by 208
White matter degeneration in vascular and other ageing‐related dementias
Hase, Y., Horsburgh, K. J., Ihara, M., & Kalaria, R. N. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14271 · Cited by 214
Nemes-Baran, A. D., White, D. R., & DeSilva, T. M. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108047 · Cited by 196
Astrocyte and Oligodendrocyte Cross-Talk in the Central Nervous System
Nutma, E., van Gent, D., Amor, S., & Peferoen, L. A. N. (2020) · Cells · doi:10.3390/cells9030600 · Cited by 196
Diagnosis, prognosis, and treatment of leukodystrophies
van der Knaap, M. S., Schiffmann, R., Mochel, F., & Wolf, N. I. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30143-7 · Cited by 175
Köhler, W., Curiel, J., & Vanderver, A. L. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.175 · Cited by 158
Role of Ceramidases in Sphingolipid Metabolism and Human Diseases
Parveen, F., Bender, D. A., Law, S., Mishra, V. K., Chen, C.-C., & Ke, L. (2019) · Cells · doi:10.3390/cells8121573 · Cited by 152
Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches
Shaimardanova, A. A., Chulpanova, D. S., Solovyeva, V. V., Mullagulova, A. I., Kitaeva, K. V., Allegrucci, C., & Rizvanov, A. A. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.576221 · Cited by 146
A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis
Nutma, E., Stephenson, J. A., Gorter, R. P., de Bruin, J., Boucherie, D. M., Donat, C. K., Breur, M., van der Valk, P., Matthews, P. M., Owen, D. R., et al. (2019) · Brain · doi:10.1093/brain/awz287 · Cited by 138
“The astrocytic contribution of the TSPO signal could also complicate differentiation of multiple sclerosis from leukody-strophies that have significant astrocytic but not microglial involvement (van der Knaap and Bugiani, 2017).”
The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies
Dalefield, M. L., Scouller, B., Bibi, R., & Kivell, B. M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.837671 · Cited by 130
Vanishing white matter: a leukodystrophy due to astrocytic dysfunction
Bugiani, M., Vuong, C., Breur, M., & van der Knaap, M. S. (2018) · Brain Pathology · doi:10.1111/bpa.12606 · Cited by 106
Self-citationLoss of the sphingolipid desaturase DEGS1 causes hypomyelinating leukodystrophy
Pant, D. C., Dorboz, I., Schlüter, A., Fourcade, S., Launay, N., Joya, J., Aguilera, S., Yoldi, M. E., Casasnovas, C., Willis, M. J. H., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123959 · Cited by 99
Yan, H., Helman, G., Murthy, S. E., Ji, H., Crawford, J., Kubisiak, T., Bent, S. J., Xiao, J., Taft, R. J., Coombs, A. M., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.09.011 · Cited by 95
Adult Leukodystrophies: A Step-by-Step Diagnostic Approach
Resende, L. L., de Paiva, A. R. B., Kok, F., Leite, C. D. C., & Lucato, L. T. (2019) · Radiographics · doi:10.1148/rg.2019180081 · Cited by 94
White matter microglia heterogeneity in the CNS
Amor, S., McNamara, N. B., Gerrits, E., Marzin, M. C., Kooistra, S. M., Miron, V. E., & Nutma, E. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02389-x · Cited by 89
Papapetropoulos, S., Pontius, A., Finger, E. C., Karrenbauer, V. D., Lynch, D. S., Brennan, M. J., Zappia, S., Koehler, W., Schöls, L. J., Hayer, S. N., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.788168 · Cited by 80
Ashrafi, M. R., Amanat, M., Garshasbi, M., Kameli, R., Nilipour, Y., Heidari, M., Rezaei, Z., & Tavasoli, A. R. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1699060 · Cited by 83
Strategies for Oligodendrocyte and Myelin Repair in Traumatic CNS Injury
Huntemer-Silveira, A., Patil, N., Brickner, M. A., & Parr, A. M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.619707 · Cited by 72
RNA Polymerase III Subunit Mutations in Genetic Diseases
Lata, E., Choquet, K., Sagliocco, F. A., Brais, B., Bernard, G., & Teichmann, M. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.696438 · Cited by 70
Hamilton, N., Rutherford, H. A., Petts, J. J., Isles, H. M., Weber, T., Henneke, M., Gärtner, J., Dunning, M., & Renshaw, S. A. (2020) · Glia · doi:10.1002/glia.23829 · Cited by 63
Single-cell transcriptomic landscape of the developing human spinal cord
Andersen, J., Thom, N., Shadrach, J. L., Chen, X., Onesto, M. M., Amin, N. D., Yoon, S.-J., Li, L., Greenleaf, W. J., Müller, F., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01311-w · Cited by 61
Biallelic variants in LARS2 and KARS cause deafness and (ovario)leukodystrophy
van der Knaap, M. S., Bugiani, M., Mendes, M. I. S., Riley, L. G., Smith, D. E. C., Rudinger‐Thirion, J., Frugier, M., Breur, M., Crawford, J., van Gaalen, J., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007098 · Cited by 52
Self-citationHeterogeneity of white matter astrocytes in the human brain
Bugiani, M., Plug, B. C., Man, J. H. K., Breur, M., & van der Knaap, M. S. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02391-3 · Cited by 55
Self-citationActivated Microglia in Cortical White Matter Across Cognitive Aging Trajectories
Gefen, T. D., Kım, G., Bolbolan, K., Geoly, A. D., Ohm, D. T., Oboudiyat, C., Shahidehpour, R. K., RADEMAKER, A. W., Weıntraub, S., Bigio, E. H., et al. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00094 · Cited by 50
Berdowski, W. M., van der Linde, H. C., Breur, M., Oosterhof, N., Beerepoot, S., Sanderson, L. E., Wijnands, L. I., de Jong, P., Tsai-Meu-Chong, E., de Valk, W. G., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02440-5 · Cited by 52
Self-citationDiattenuation Imaging reveals different brain tissue properties
Menzel, M., Axer, M., Amunts, K., Raedt, H. A. D., & Michielsen, K. F. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-38506-w · Cited by 49
Pelletier, F., Perrier, S., Cayami, F. K., Mirchi, A., Saïkali, S., Tran, L. T., Ulrick, N., Guerrero, K., Rampakakis, E., van Spaendonk, R. M. L., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa700 · Cited by 47
Schmidt, J., Pizzino, A. M., Nicholl, J., Foley, A. L., Wang, Y., Rosenfeld, J. A., Mighion, L. C., Bean, L. J., da Silva, C., Cho, M. T., et al. (2020) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61641 · Cited by 46
García‐Mateo, N., Pascua‐Maestro, R., Pérez‐Castellanos, A., Lillo, C., Sánchez, D., & Ganfornina, M. D. (2017) · Glia · doi:10.1002/glia.23274 · Cited by 46
Monocarboxylate Transporter 8 Deficiency: Delayed or Permanent Hypomyelination?
Vancamp, P., DEMENEIX, B. A., & Remaud, S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00283 · Cited by 43
Breaking down the cellular responses to type I interferon neurotoxicity in the brain
Viengkhou, B., & Hofer, M. J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1110593 · Cited by 41
Genome sequencing in persistently unsolved white matter disorders
Helman, G., Lajoie, B. R., Crawford, J., Takanohashi, A., Walkiewicz, M., Dolzhenko, E., Gross, A. M., Gainullin, V. G., Bent, S. J., Jenkinson, E. M., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50957 · Cited by 39
Elitt, M. S., Shick, H. E., Madhavan, M., Allan, K. C., Clayton, B. L. L., Weng, C., Miller, T. E., Factor, D. C., Barbar, L., Nawash, B. S., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.07.015 · Cited by 39
Chanoumidou, K., Hernández-Rodríguez, B., Windener, F., Thomas, C., Stehling, M., Mozafari, S., Albrecht, S., Ottoboni, L., Antel, J., Kim, K.-P., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.03.001 · Cited by 39
Biallelic KARS pathogenic variants cause an early-onset progressive leukodystrophy
Itoh, M., Dai, H., Horike, S., Gonzalez, J., Kitami, Y., Meguro‐Horike, M., Kuki, I., Shimakawa, S., Yoshinaga, H., Ota, Y., et al. (2019) · Brain · doi:10.1093/brain/awz001 · Cited by 38
Zhou, L., Li, P., Chen, N., Dai, L., Gao, K., Liu, Y., Shen, L., Wang, J., Jiang, Y., & Wu, Y. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13107 · Cited by 38
Astrocyte–Oligodendrocyte–Microglia Crosstalk in Astrocytopathies
de Waard, D. M., & Bugiani, M. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.608073 · Cited by 38
Self-citationWu, C., Wang, M., Wang, X., Li, W., Li, S., Chen, B., Niu, S., Tai, H., Pan, H., & Zhang, Z. (2022) · Brain · doi:10.1093/brain/awac426 · Cited by 37
Viengkhou, B., Hayashida, E., McGlasson, S. L., Emelianova, K., Forbes, D., Wiseman, S. J., Wardlaw, J. M., Verdillo, R., Irani, S. R., Duffy, D., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.05.017 · Cited by 37
Mickeviciute, G., Valiuskyte, M., Plattén, M., Wszołek, Z. K., Andersen, O., Karrenbauer, V. D., Ineichen, B. V., & Granberg, T. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13420 · Cited by 37
Elevated Leukodystrophy Incidence Predicted From Genomics Databases
Soderholm, H. E., Chapin, A., Bayrak‐Toydemir, P., & Bonkowsky, J. L. (2020) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2020.06.005 · Cited by 35
Bölsterli, B. K., Boltshauser, E., Palmieri, L., Spenger, J., Brunner‐Krainz, M., Distelmaier, F., Freisinger, P., Geis, T., Gropman, A. L., Häberle, J., et al. (2022) · Nutrients · doi:10.3390/nu14173605 · Cited by 35
The Primary Microglial Leukodystrophies: A Review
Ferrer, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116341 · Cited by 35
Genotypic Spectrum and Natural History of Cavitating Leukoencephalopathies in Childhood
Zhang, J., Liu, M., Zhang, Z., Zhou, L., Kong, W., Jiang, Y., Wang, J., Xiao, J., & Wu, Y. (2019) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2019.01.002 · Cited by 34
Oligodendrocyte pathology in Huntington’s disease: from mechanisms to therapeutics
Bardile, C. F., Radulescu, C. I., & Pouladi, M. A. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.07.010 · Cited by 38
Glial cells in the driver seat of leukodystrophy pathogenesis
Garcia, L., Hacker, J. L., Sase, S., Adang, L. A., & Almad, A. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105087 · Cited by 34
Khalaf, G., Mattern, C., Bégou, M., Boespflug‐Tanguy, O., Massaad, C., & Massaad-Massade, L. (2022) · Biomedicines · doi:10.3390/biomedicines10071709 · Cited by 35
Komada, M., & Nishimura, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.852752 · Cited by 32
Biallelic mutations in NRROS cause an early onset lethal microgliopathy
Smith, C., McColl, B. W., Patir, A., Barrington, J., Armishaw, J., Clarke, A., Eaton, J., Hobbs, V., Mansour, S., Nolan, M. A., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02137-7 · Cited by 31
Rivellini, C., Porrello, E., Dina, G., Mrakic-Sposta, S., Vezzoli, A., Bacigaluppi, M., Gullotta, G. S., Chaabane, L., Leocani, L., Marenna, S., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145071 · Cited by 32
Adult-onset leukodystrophies: a practical guide, recent treatment updates, and future directions
Muthusamy, K., Sivadasan, A., Dixon, L. V. M., Sudhakar, S. V., Thomas, M. M., Danda, S., Wszołek, Z. K., Wierenga, K. J., Dhamija, R., & Gavrilova, R. H. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1219324 · Cited by 30
Randomized Clinical Trial of First‐Line Genome Sequencing in Pediatric White Matter Disorders
Vanderver, A. L., Bernard, G., Helman, G., Sherbini, O., Boeck, R., Cohn, J., Collins, A. R., Demarest, S., Dobbins, K., Emrick, L., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25757 · Cited by 30
Biswas, A., Malhotra, M., Mankad, K., Carney, O., D’Arco, F., Muthusamy, K., & Sudhakar, S. V. (2021) · Translational Pediatrics · doi:10.21037/tp-20-335 · Cited by 30
Defective myelination in an RNA polymerase III mutant leukodystrophic mouse
Merheb, E., Cui, M., DuBois, J. C., Branch, C. A., Gulinello, M. E., Shafit‐Zagardo, B., Moir, R. D., & Willis, I. M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2024378118 · Cited by 30
Cerebral hypomyelination associated with biallelic variants of FIG4
Lenk, G. M., Berry, I. R., Stutterd, C., Blyth, M., Green, L., Vadlamani, G., Warren, D., Craven, I., Fanjul‐Fernández, M., Rodriguez‐Casero, V., et al. (2019) · Human Mutation · doi:10.1002/humu.23720 · Cited by 29
Adang, L. A., Sevagamoorthy, A., Sherbini, O., Fraser, J. L., Bonkowsky, J. L., Gavazzi, F., D'Aiello, R., Modesti, N. B., Yu, E. J., Mutua, S., et al. (2024) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2024.108453 · Cited by 28
Zhou, W., Xia, S., Wang, C., Yang, Q., Verkhratsky, A., & Niu, J. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07893-6 · Cited by 31
Schaefers, J., van der Giessen, L. J., Klees, C., Jacobs, E. H., Sieverdink, S., Dremmen, M. H. G., Spoor, J. K. H., van der Ploeg, A. T., van den Hout, J. M. P., & Huidekoper, H. H. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-01858-6 · Cited by 28
Autosomal Dominant Leukodystrophy: A Disease of the Nuclear Lamina
Padiath, Q. S. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00041 · Cited by 30
Phenotypic diversity of brain MRI patterns in mitochondrial aminoacyl-tRNA synthetase mutations
Roux, C., Barcia, G., Schiff, M., Sissler, M., Levy, R., Dangouloff‐Ros, V., Desguerre, I., Edvardson, S., Elpeleg, O., Rötig, A., et al. (2021) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2021.04.004 · Cited by 28
AGC1 Deficiency: Pathology and Molecular and Cellular Mechanisms of the Disease
Pardo, B., Herrada-Soler, E., Satrústegui, J., Contreras, L., & del Arco, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010528 · Cited by 31
Alfadhel, M., Almuqbil, M., Mutairi, F. A., Umair, M., Almannai, M., Alghamdi, M. A., Althiyab, H., Albarakati, R., Bashiri, F. A., Alshuaibi, W., et al. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.633385 · Cited by 25
Biallelic mutations in RNF220 cause laminopathies featuring leukodystrophy, ataxia and deafness
Sferra, A., Fortugno, P., Motta, M., Aiello, C., Petrini, S., Ciolfi, A., Cipressa, F., Moroni, I., Leuzzi, V., Pieroni, L., et al. (2021) · Brain · doi:10.1093/brain/awab185 · Cited by 25
Pace, R. D., Maroofian, R., Paimboeuf, A., Zamani, M., Zaki, M. S., Sadeghian, S., Malamiri, R. A., Galehdari, H., Zeighami, J., Williamson, C. D., et al. (2023) · Brain · doi:10.1093/brain/awad427 · Cited by 25
Neural stem cells restore myelin in a demyelinating model of Pelizaeus-Merzbacher disease
Gruenenfelder, F. I., McLaughlin, M., Griffiths, I. R., Garbern, J. Y., Thomson, G., Kuzman, P., Barrie, J. A., McCulloch, M. C., Penderis, J., Stassart, R. M., et al. (2020) · Brain · doi:10.1093/brain/awaa080 · Cited by 25
Plug, B. C., Revers, I. M., Breur, M., González, G. M., Timmerman, J. A., Meijns, N. R. C., Hamberg, D., Wagendorp, J., Nutma, E., Wolf, N. I., et al. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01784-1 · Cited by 25
Self-citationOligodendrocyte differentiation alters tRNA modifications and codon optimality-mediated mRNA decay
Martin, S., Allan, K. C., Pinkard, O. W., Sweet, T. J., Tesar, P. J., & Coller, J. (2022) · Nature Communications · doi:10.1038/s41467-022-32766-3 · Cited by 25
Update on leukodystrophies and developing trials
Ceravolo, G., Zhelcheska, K., Squadrito, V., Pellerin, D., Gitto, E., Hartley, L., & Houlden, H. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11996-5 · Cited by 26
Ikeuchi, T., Mezaki, N., & Miura, T. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.08.018 · Cited by 24
Leukodystrophies and genetic leukoencephalopathies in children
Sarret, C. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2019.04.003 · Cited by 24
Hypomyelinating leukodystrophies in adults: Clinical and genetic features
Bella, D. D., Magri, S., Benzoni, C., Farina, L., Maccagnano, C., Sarto, E., Moscatelli, M. E. M., Baratta, S., Ciano, C., Piacentini, S. H. M. J., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14646 · Cited by 23
Helman, G., Takanohashi, A., Hagemann, T. L., Perng, M. D., Walkiewicz, M., Woidill, S., Sase, S., Cross, Z., Du, Y., Zhao, L., et al. (2020) · Human Mutation · doi:10.1002/humu.24008 · Cited by 23
Epilepsy in children with leukodystrophies
Zhang, J., Ban, T., Zhou, L., Ji, H., Yan, H., Shi, Z., Cao, B., Jiang, Y., Wang, J., & Wu, Y. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09889-y · Cited by 22
Quantitative MRI in leukodystrophies
Stellingwerff, M. D., Pouwels, P. J. W., Roosendaal, S. D., Barkhof, F., & van der Knaap, M. S. (2023) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103427 · Cited by 23
Dufour, B. D., Bartley, T., McBride, E., Allen, E., McLennan, Y. A., Hagerman, R. J., & Martínez‐Cerdeño, V. (2023) · Annals of Neurology · doi:10.1002/ana.26851 · Cited by 22
Update on pediatric-onset multiple sclerosis
Ruet, A. (2018) · Revue Neurologique · doi:10.1016/j.neurol.2018.04.003 · Cited by 24
Animal models of leukodystrophy: a new perspective for the development of therapies
Rutherford, H. A., & Hamilton, N. (2019) · FEBS Journal · doi:10.1111/febs.15060 · Cited by 22
The pathology of X-linked adrenoleukodystrophy: Tissue specific changes as a clue to pathophysiology
Yska, H. A. F., Engelen, M., & Bugiani, M. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03105-0 · Cited by 20
Self-citationSafety and Efficacy of Intravenous and Intrathecal Delivery of AAV9-Mediated ARSA in Minipigs
Mullagulova, A. I., Shaimardanova, A. A., Solovyeva, V. V., Mukhamedshina, Y. O., Chulpanova, D. S., Kostennikov, A., Issa, S. S., & Rizvanov, A. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119204 · Cited by 20
Oligodendrocytes in central nervous system diseases: the effect of cytokine regulation
Zhang, C., Qiu, M. S., & Fu, H. Q. (2024) · Neural Regeneration Research · doi:10.4103/1673-5374.392854 · Cited by 21
Thomas, A., & Thomas, A. K. (2019) · Journal of Clinical Imaging Science · doi:10.25259/jcis_116_2019 · Cited by 20
Friederich, M. W., Perez, F. A., Knight, K. M., Hove, R. A. V., Yang, S. P., Saneto, R. P., & Hove, J. L. K. V. (2019) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2019.12.013 · Cited by 20
POLR3-Related Leukodystrophy: Exploring Potential Therapeutic Approaches
Perrier, S., Michell‐Robinson, M. A., & Bernard, G. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.631802 · Cited by 23
Canavan Disease as a Model for Gene Therapy-Mediated Myelin Repair
Lotun, A., Gessler, D. J., & Gao, G. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.661928 · Cited by 20
Zhong, Y., Liang, B., Meng, H., Ye, R., Li, Z., Du, J., Wang, B., Zhang, B., Huang, Y., Lin, X., et al. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113180 · Cited by 20
Early-Onset Vascular Leukoencephalopathy Caused by Bi-Allelic NOTCH3 Variants
Stellingwerff, M. D., Nulton, C., Helman, G., Roosendaal, S. D., Benko, W. S., Pizzino, A. M., Bugiani, M., Vanderver, A. L., Simons, C., & van der Knaap, M. S. (2022) · Neuropediatrics · doi:10.1055/a-1739-2722 · Cited by 19
Self-citationZhang, S., Hu, Y., Yang, H., Li, Q., Chen, J., & Bai, H. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1096808 · Cited by 19
Claudin-11 in health and disease: implications for myelin disorders, hearing, and fertility
Gjervan, S. C., Ozgoren, O. K., Gow, A., Stöckler‐Ipsiroglu, S., & Pouladi, M. A. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1344090 · Cited by 20
Brain macrophages in vascular health and dysfunction
Bijnen, M., Sridhar, S., Keller, A., & Greter, M. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.11.012 · Cited by 20
Clinical approach to neurodegenerative disorders in childhood: an updated overview
Mastrangelo, M. (2019) · Acta Neurologica Belgica · doi:10.1007/s13760-019-01160-0 · Cited by 20
Kavanaugh, B. C., Warren, E. B., Baytaş, O., Schmidt, M., Merck, D. L., Buch, K. A., Liu, J. S.-H., Phornphutkul, C., Caruso, P. A., & Morrow, E. M. (2019) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61322 · Cited by 19
Viengkhou, B., Hong, C., Mazur, C., Damle, S. S., Gallo, N. B., Fang, T., Henry, K. L., Campbell, I. L., Kamme, F., & Hofer, M. J. (2024) · Journal of Clinical Investigation · doi:10.1172/jci169562 · Cited by 18
The clinical and genetic spectrum of inherited glycosylphosphatidylinositol deficiency disorders
Sidpra, J., Sudhakar, S. V., Biswas, A., Massey, F., Turchetti, V., Lau, T., Cook, E., Alvi, J. R., Elbendary, H. M., Jewell, J., et al. (2024) · Brain · doi:10.1093/brain/awae056 · Cited by 18
Megalencephalic leukoencephalopathy with subcortical cysts: A personal biochemical retrospective
Estévez, R., Elorza‐Vidal, X., Gaitán‐Peñas, H., Pérez‐Rius, C., Armand‐Ugón, M., Alonso-Gardón, M., Xicoy-Espaulella, E., Sirisi, S., Arnedo, T., Capdevila‐Nortes, X., et al. (2017) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2017.10.013 · Cited by 18
White Matter Lesions in Adults – a Differential Diagnostic Approach
Weidauer, S., Wagner, M., & Hattingen, E. (2020) · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · doi:10.1055/a-1207-1006 · Cited by 19
Genetic disorders with central nervous system white matter abnormalities: An update
Shukla, A., Kaur, P., Narayanan, D. L., do Rosario, M. C., Kadavigere, R., & Girisha, K. M. (2020) · Clinical Genetics · doi:10.1111/cge.13863 · Cited by 18
Diagnostic approach in multiple sclerosis with MRI: an update
Weidauer, S., Raab, P., & Hattingen, E. (2021) · Clinical Imaging · doi:10.1016/j.clinimag.2021.05.025 · Cited by 19
Metadata
- Authors
- van der Knaap, M. S., & Bugiani, M.
- Affiliations
- Amsterdam Neuroscience (NL)
- Corresponding author
- Bugiani, Marianna
- Venue
- Acta Neuropathologica
- Published
- 2017-06-21
- Volume
- 134
- Issue
- 3
- Pages
- 351-382
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC5563342
- OpenAlex
- W2653495475
- Cited by
- 403
- References
- 276
- Citations by year
- 2026: 32 · 2025: 49 · 2024: 79 · 2023: 52 · 2022: 36 · 2021: 51 · 2020: 39 · 2019: 45 · 2018: 13 · 2017: 5
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Acta Neuropathologica (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- VU Research Portal (publishedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Vrije Universiteit Amsterdam
- Fonds NutsOhra
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Keywords
- leukodystrophy, white matter pathology, hypomyelinating leukodystrophy, astrocytopathy, oligodendrocytes, myelin disorders, neuropathology, disease mechanisms
- MeSH terms
- Axons, Demyelinating Diseases, Humans, Myelin Sheath, Neuroglia, White Matter
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review